A shockingly high number of dogs, mice, cats, rabbits and other animals are still suffering in invasive, painful and sometimes lethal experiments in British laboratories. More: Animal experiment stats show reluctance to embrace modern tools Source: News
read moreEncouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO More: Bayer, BMS, Ono team up to investigate Stivarga, Opdivo combo Source: News
read moreThe antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties. More: Robots to help produce new class of antibiotics Source: News
read moreUnder the terms of the deal Bridge Biotherapeutics will receive upfront and near term payments of EUR 45million and is eligible to receive up to more than EUR 1.1billion in potential payments. More: Boehringer expands IPF pipeline with addition of
read moreALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and the spinal cord. More: Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk Source: News
read moreBristol-Myers Squibb is out to expand the pool of colorectal cancer patients it can treat with Opdivo—and it’s bringing in Bayer to help. The duo plan to test the I-O star alongside Bayer’s Stivarga, hoping to gain a new FDA
read more© 1994 - 2026 B.M. Pharmaceuticals